Clinical Trials Sponsored by Novartis
Total 4715 results
-
Novartis PharmaceuticalsActive, not recruitingMelanomaItaly, Czechia, Germany, Hungary, Canada, United States, Argentina, Australia, Austria, France, Israel, Russian Federation, Spain, Sweden, United Kingdom, Thailand, Belgium, Brazil, Greece, Switzerland, Mexico, Netherlands, Denmark, C... and more
-
Novartis PharmaceuticalsCompletedTreatment-Resistant DepressionSpain, Japan, Poland, United States
-
Novartis PharmaceuticalsCompletedNeovascular Age-related Macular DegenerationItaly
-
Novartis PharmaceuticalsCompletedHeart FailureUnited States, Italy, Croatia, India, Japan, Poland, Spain, Taiwan, Austria, Korea, Republic of, Germany, Lebanon, Thailand, Canada, Bulgaria, Russian Federation, Turkey, Switzerland, Argentina, Hungary, Portugal, Finland, South Africa and more
-
Novartis PharmaceuticalsCompletedChronic Spontaneous UrticariaJapan
-
Novartis PharmaceuticalsActive, not recruitingStudy of Efficacy, Safety, and Tolerability of LNA043 in Patients With Knee Osteoarthritis (ONWARDS)OsteoarthritisTaiwan, Spain, United Kingdom, United States, Argentina, Australia, Denmark, India, China, Czechia, Canada, Japan, Poland, Mexico, Estonia
-
Novartis PharmaceuticalsActive, not recruitingMigraineChina, Taiwan, Korea, Republic of, Thailand, India, Singapore, Malaysia, Philippines, Vietnam
-
Novartis PharmaceuticalsCompletedTransfusion-dependent AnemiaEgypt, Hungary, Turkey, United States, Bulgaria, Italy, Belgium, Russian Federation, Philippines, France, Malaysia, India, Oman, Panama, Lebanon, Thailand, Tunisia
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedAtherosclerotic Cardiovascular Disease | Atherosclerotic Cardiovascular Disease Risk Equivelents | Elevated Low Density Lipoprotein CholesterolUnited Kingdom
-
Novartis PharmaceuticalsActive, not recruitingNon-Hodgkin LymphomaSpain, Taiwan, Australia, Belgium, Germany, Italy, Singapore, Austria, France, Switzerland, Hong Kong, United States, Netherlands, Norway, United Kingdom, Brazil, China, Japan
-
Novartis PharmaceuticalsActive, not recruitingMetastatic Castration-Resistant Prostate Cancer (mCRPC)China
-
Novartis PharmaceuticalsCompletedNon-Hodgkin LymphomaJapan, Spain, Germany, Australia, Austria, Canada, Italy, Norway, United States, United Kingdom, Finland, France, Denmark, Netherlands
-
Novartis PharmaceuticalsActive, not recruitingModerate to Severe Chronic Plaque PsoriasisChina
-
Novartis PharmaceuticalsCompletedModerate to Severe Chronic Plaque-type PsoriasisBelgium, Spain, Russian Federation, Germany, United States, Czechia, Peru, Poland, Estonia
-
Novartis PharmaceuticalsActive, not recruiting
-
Novartis PharmaceuticalsAvailable
-
Novartis PharmaceuticalsActive, not recruitingMultiple Myeloma (MM)United States, Italy, Israel, Germany, Japan, Spain, Australia, Norway
-
Novartis PharmaceuticalsCompletedDiabetic Macular EdemaCzechia, India, Russian Federation, Taiwan, Turkey, Lebanon, Denmark, Estonia, France, Germany, Hungary, Korea, Republic of, Latvia, Lithuania, Bulgaria, Norway, Belgium, Malaysia, Sweden, Slovakia, Singapore, Poland, Switzerland
-
Novartis PharmaceuticalsTerminatedPoor Graft FunctionSpain
-
Novartis PharmaceuticalsActive, not recruitingTriple Negative Breast NeoplasmsFrance, Italy, Croatia, Taiwan, Australia, Argentina, Korea, Republic of, China, Israel, Russian Federation, Slovakia, Slovenia, United Kingdom, Germany, Mexico, Switzerland, Spain, Brazil, Hungary, Malaysia, South Africa, Austria, ... and more
-
Novartis PharmaceuticalsActive, not recruitingType 2 Spinal Muscular AtrophyUnited States, China, Saudi Arabia, Thailand, Singapore, Brazil, Malaysia, Taiwan, Colombia, Mexico, Denmark, Egypt, India, South Africa, Vietnam
-
Novartis PharmaceuticalsCompletedDiffuse Large B-cell LymphomaUnited States
-
Novartis PharmaceuticalsTerminated
-
Novartis PharmaceuticalsCompletedSecondary Progressive Multiple Sclerosis (SPMS)Japan
-
Novartis PharmaceuticalsCompletedBRAF-positive Metastatic MelanomaUnited States
-
Novartis PharmaceuticalsAvailablePrimary Myelofibrosis (PMF) | Polycythemia Vera (PV) | Post Polycythemia Myelofibrosis (PPV MF) | Thrombocythemia Myelofibrosis (PET-MF) | Severe/Very Severe COVID-19 Illness | Steroid Refractory Acute Graft Versus Host Disease (SR aGVHD) | Steroid Refractory Chronic Graft Versus Host Disease...
-
Novartis PharmaceuticalsAvailableNon-Small Cell Lung Cancer | Nonsmall Cell Lung Cancer | Carcinoma, Non-Small Cell Lung | Non-Small-Cell Lung Carcinoma
-
Novartis PharmaceuticalsAvailablePIK3CA-Related Overgrowth Spectrum (PROS)
-
Novartis PharmaceuticalsCompletedEarly Manifest Huntington DiseaseCanada, Germany, France, Spain, Hungary
-
Novartis PharmaceuticalsCompletedMigraine | Migraine Disorders | Migraine HeadacheGermany
-
Novartis PharmaceuticalsTerminatedLupus NephritisChina, Croatia, Czechia, Russian Federation, Turkey, Australia, Spain, Thailand, Argentina, United States, Denmark, Greece, Romania, Germany, Korea, Republic of, India, Brazil, Japan, Peru, Portugal, Italy, Taiwan, Vietnam, Norway, Colo... and more
-
Novartis PharmaceuticalsCompletedNon-Small Cell Lung CancerItaly, Spain, Taiwan, Germany, Netherlands, Singapore, Austria, Japan, Australia, France, Russian Federation, Sweden, Thailand, Korea, Republic of, Lebanon, Norway, United Kingdom, China, India, Brazil, Turkey, Poland, Denmark, Greece, ... and more
-
Novartis PharmaceuticalsCompletedAnkylosing SpondylitisIndia, Turkey, Belgium, Thailand, United States, Czechia, Greece, Russian Federation, Bulgaria, Guatemala, Italy, Korea, Republic of, Malaysia, Sweden, Colombia, Philippines, Poland, Brazil
-
Novartis PharmaceuticalsTerminatedColorectal Cancer | Gastrointestinal Stromal Tumors | Non-small Cell Lung Carcinoma | Head and Neck Squamous Cell Carcinoma | Esophageal SCCUnited States, Germany, Spain, Singapore, Australia, Hong Kong, Belgium, Japan, China
-
Novartis PharmaceuticalsTerminatedTriple Negative Breast Cancer (TNBC)Netherlands, Spain, Hong Kong, Singapore, Italy, Australia, Israel, Japan, United States
-
Novartis PharmaceuticalsActive, not recruitingSpinal Muscular AtrophyJapan, Belgium, Spain, Canada, United States, Australia, Italy, France, Netherlands
-
Novartis PharmaceuticalsTerminatedAdvanced Solid TumorsSpain, Japan, Taiwan, Italy, Switzerland, Israel, United States, Singapore
-
Novartis PharmaceuticalsTerminatedIn Escalation: All Patients With Solid Tumors and Lymphoma | In Expansion: Melanoma, Non-small Cell Lung CancerUnited States, Italy, Taiwan, Belgium, Spain, Germany, Japan
-
Novartis PharmaceuticalsCompletedSpinal Muscular AtrophyTaiwan, Belgium, Canada, United States, Australia, France, Italy, Portugal, United Kingdom
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsActive, not recruitingSickle Cell DiseaseUnited States
-
Novartis PharmaceuticalsCompletedNeovascular (Wet) Age-related Macular DegenerationUnited States
-
Novartis PharmaceuticalsCompletedImmune Thrombocytopenic Purpura (ITP)Spain, Italy, Greece, Switzerland, United Kingdom, France, Turkey, Russian Federation, Brazil, Austria, Mexico, Oman, Chile, Japan, United States
-
Novartis PharmaceuticalsCompletedNeovascular Age-related Macular DegenerationUnited States
-
Novartis PharmaceuticalsActive, not recruitingRetinitis PigmentosaSweden
-
Novartis PharmaceuticalsCompletedPsoriasis | Psoriatic ArthritisSwitzerland
-
Novartis PharmaceuticalsActive, not recruitingNon-small Cell Lung CancerUnited States